+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cardiac Bio Implant Devices Market, Size, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis

  • ID: 5562703
  • Report
  • March 2022
  • Region: Global
  • 135 Pages
  • Renub Research

FEATURED COMPANIES

  • Agilent Technologies
  • Eurofins Scientific
  • F. Hoffman-La Roche
  • Illumina, Inc.
  • Natera, Inc.
  • PerkinElmer Inc.
Global Cardiac Bio Implant Devices Market is anticipated to reach US$ 51.21 Billion in 2028. Over the years, high cholesterol, smoking, and high blood pressure has been linked to cardiac illness. Other conditions, such as diabetes and obesity and lifestyle changes such as poor nutrition, excessive alcohol use, and physical inactivity, have been increasing the risk of cardiac disease. Hence, Cardiac Bio Implant Devices are electronic ormechanical implantable devices developed to aid in the treatment of cardiac disorders. Long-term cardiac problems, such as heart failure and other heart dysfunctions, are treated with these devices. Furthermore, the second stage of cardiac treatment involves implanting devices inside the patient's body.



Worldwide Cardiac Bio Implant Devices Industry will grow at a CAGR of 7.3% from 2021-2028


The increasing prevalence and awareness of cardiovascular disorders drive the Global Cardiac Bio Implant Devices Market. Furthermore, non-communicable diseases such as diabetes, hypertension, obesity, and others are causing a significant increase in new cases in developed countries. In contrast, lifestyle disorders such as smoking and alcoholism put developing countries with limited healthcare infrastructure at risk. As a result of their increased sensitivity to heart failure, the populations impacted by these illnesses will be a significant driver of demand in the coming years.

CRT (Cardiac Resynchronization Therapy) Is Determined to Be the Most Effective:


in the analysis, the market has been categorized into Pacemaker, ICDs (Implantable Cardioverter Defibrillator), and CRTs (Cardiac Resynchronization Therapy). According to our calculations, the CRT (Cardiac Resynchronization Therapy) market will be dominating in 2021 and throughout the study period. CRT is a clinically validated therapeutic option for some people with heart failure. Furthermore, the CRT device transmits mild electrical impulses to both heart's lower chambers to help them beat in a more coordinated way. Additionally, the heart's ability to pump blood and oxygen throughout the body is expected to improve.

Impacts of the COVID-19 Pandemic on Cardiac Bio-Implant Industry:


Most sectors throughout the world have been significantly impacted due to significant disruptions to their manufacturing and supply-chain operations due to various precautionary lockdowns and other limitations imposed by regulatory authorities around the world. The global Cardiac Bio Implant Devices market is no exception. As the prevailing economic condition of most people was adversely affected by the outbreak, consumer demand was reduced as people were keener on removing non-essential expenses from their separate budgets. However, the global Cardiac Bio Implant Devices market recovered as different government authorities began to break the enforced lockdowns in 2020. According to the publisher report, The Global Cardiac Bio Implant Devices Market Size was US$ 31.29 Billion in 2021.

Throughout The Study Period, Myocardial Ischemia Continues to Be the Leading Cause of Death:


In our report, By Applications, the Global Cardiac Bio Implant Devices Market is divided into Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, and Heart Failure. According to our findings, Myocardial Ischemia continues to be the leading cause of death during the study period. A condition known as myocardial ischemia occurs when the heart muscles do not receive enough blood. It could be because of a deficiency of oxygenated blood in this area or blockages in the coronary arteries, the leading supplier of these nutrients and oxygen. Myocardial Ischemia has several advantages, including preventing sudden death from strokes and a decrease in mortality rates among individuals with heart disease.

Regional Realms of the Global Cardiac Bio Implant Devices Market:


During the projection period of 2021-2028, Asia-Pacific is expected to dominate the market and increase steadily. The high prevalence of chronic diseases, combined with rising disposable income, has resulted in a higher acceptance rate for medical treatments such as implants, among other things, across the globe, especially in India and China. Similarly, the European market is expected to rise steadily, owing to an increase in the senior population and the increased prevalence of the cardiovascular disease. Furthermore, many cardiac implant device manufacturers in Europe have resulted in severe competition between them in terms of production costs while also ensuring that quality standards are maintained.

Key Players in the Market:


Our report examines the Global Cardiac Bio Implant Devices Market in-depth, outlining its competitive landscape, potential growth opportunities, and potential pitfalls, as well as providing information on market participants such as Agilent Technologies, Eurofins Scientific, F. Hoffman-La Roche, Illumina, Inc., Natera, Inc., PerkinElmer Inc., Quest Diagnostics, and Thermo Fisher Scientific. Key players are more engaged with launching techniques such as focused marketing and CSR activities to enhance worldwide significance.

The publisher's latest report Cardiac Bio Implant Devices Market, Global Forecast By Type (Pacemaker, ICDs (Implantable Cardioverter Defibrillator), CRT (Cardiac Resynchronization Therapy), Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Heart Failure), End-User (Hospitals, Cardiac Care Centers, Ambulatory Centers & Home Care, Academic Institutes, Others), Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, Companies (Agilent Technologies, Eurofins Scientific, F. Hoffman-La Roche, Illumina, Inc., Natera, Inc., PerkinElmer Inc., Quest Diagnostics, and Thermo Fisher Scientific) provides a detailed analysis of Cardiac Bio Implant Devices Industry.

Type - Market have been covered from 3 viewpoints:


1. Pacemaker
2. ICDs (Implantable Cardioverter Defibrillator)
3. CRT (Cardiac Resynchronization Therapy)

Application - Market have been covered from 4 viewpoints:


1. Arrhythmias
2. Myocardial Ischemia
3. Acute Myocardial Infarction
4. Heart Failure

End-User - Market have been covered from 4 viewpoints:


1. Hospitals
2. Cardiac Care Centers
3. Ambulatory Centers & Home Care
4. Academic Institutes
5. Others

Region - Market have been covered from 5 viewpoints:


1. North America
2. Europe
3. Asia-Pacific
4. Latin America
5. Middle East and Africa

Company Insights:


  • Overview
  • Recent Development & Strategies
  • Revenue Analysis

Companies Covered:


1. Agilent Technologies
2. Eurofins Scientific
3. F. Hoffman-La Roche
4. Illumina, Inc.
5. Natera, Inc.
6. PerkinElmer Inc.
7. Quest Diagnostics
8. Thermo Fisher Scientific
Frequently Asked Questions about the Global Cardiac Bio Implant Devices Market

What is the estimated value of the Global Cardiac Bio Implant Devices Market?

The Global Cardiac Bio Implant Devices Market was estimated to be valued at $31.3 Billion in 2021.

What is the growth rate of the Global Cardiac Bio Implant Devices Market?

The growth rate of the Global Cardiac Bio Implant Devices Market is 7.3%, with an estimated value of $51.2 Billion by 2028.

What is the forecasted size of the Global Cardiac Bio Implant Devices Market?

The Global Cardiac Bio Implant Devices Market is estimated to be worth $51.2 Billion by 2028.

Who are the key companies in the Global Cardiac Bio Implant Devices Market?

Key companies in the Global Cardiac Bio Implant Devices Market include Agilent Technologies, Eurofins Scientific, F. Hoffman, La Roche, Illumina, Inc., Natera, Inc., PerkinElmer Inc. and Thermo Fisher Scientific.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies
  • Eurofins Scientific
  • F. Hoffman-La Roche
  • Illumina, Inc.
  • Natera, Inc.
  • PerkinElmer Inc.

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Cardiac Bio Implant Devices Market
6. Market Share - Cardiac Bio Implant Devices Market
6.1 By Type
6.2 By Application
6.3 By End-User
6.4 By Region
7. Type - Cardiac Bio Implant Devices Market
7.1 Pacemaker
7.2 ICDs (Implantable Cardioverter Defibrillator)
7.3 CRT (Cardiac Resynchronization Therapy)
8. Application - Cardiac Bio Implant Devices Market
8.1 Arrhythmias
8.2 Myocardial Ischemia
8.3 Acute Myocardial Infarction
8.4 Heart Failure
9. End-User - Cardiac Bio Implant Devices Market
9.1 Hospitals
9.2 Cardiac Care Centers
9.3 Ambulatory Centers & Home Care
9.4 Academic Institutes
9.5 Others
10. Region - Cardiac Bio Implant Devices Market
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Latin America
10.5 Middle East and Africa
11. Porters Five Forces
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12. Company Analysis
12.1 Agilent Technologies
12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue Analysis
12.2 Eurofins Scientific
12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue Analysis
12.3 F. Hoffman-La Roche
12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue Analysis
12.4 Illumina, Inc.
12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue Analysis
12.5 Natera, Inc.
12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue Analysis
12.6 PerkinElmer Inc.
12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue Analysis
12.7 Quest Diagnostics
12.7.1 Overview
12.7.2 Recent Development
12.7.3 Revenue Analysis
12.8 Thermo Fisher Scientific
12.8.1 Overview
12.8.2 Recent Development
12.8.3 Revenue Analysis
List Of Figures:
Figure 01: Global - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2021
Figure 02: Global - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2022 - 2027
Figure 03: Type - Pacemaker Market (Billion US$), 2018 - 2021
Figure 04: Type - Forecast for Pacemaker Market (Billion US$), 2022 - 2027
Figure 05: Type - ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2018 - 2021
Figure 06: Type - Forecast for ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2022 - 2027
Figure 07: Type - CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2018 - 2021
Figure 08: Type - Forecast for CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2022 - 2027
Figure 09: Application - Arrhythmias Market (Million US$), 2018 - 2021
Figure 10: Application - Forecast for Arrhythmias Market (Million US$), 2022 - 2027
Figure 11: Application - Myocardial Ischemia Market (Billion US$), 2018 - 2021
Figure 12: Application - Forecast for Myocardial Ischemia Market (Billion US$), 2022 - 2027
Figure 13: Application - Acute Myocardial Infarction Market (Billion US$), 2018 - 2021
Figure 14: Application - Forecast for Acute Myocardial Infarction Market (Billion US$), 2022 - 2027
Figure 15: Application - Heart Failure Market (Billion US$), 2018 - 2021
Figure 16: Application - Forecast for Heart Failure Market (Billion US$), 2022 - 2027
Figure 17: End-User - Hospitals Market (Billion US$), 2018 - 2021
Figure 18: End-User - Forecast for Hospitals Market (Billion US$), 2022 - 2027
Figure 19: End-User - Cardiac Care Centers Market (Billion US$), 2018 - 2021
Figure 20: End-User - Forecast for Cardiac Care Centers Market (Billion US$), 2022 - 2027
Figure 21: End-User - Ambulatory Centers & Home Care Market (Billion US$), 2018 - 2021
Figure 22: End-User - Forecast for Ambulatory Centers & Home Care Market (Billion US$), 2022 - 2027
Figure 23: End-User - Academic Institutes Market (Billion US$), 2018 - 2021
Figure 24: End-User - Forecast for Academic Institutes Market (Billion US$), 2022 - 2027
Figure 25: End-User - Others Market (Billion US$), 2018 - 2021
Figure 26: End-User - Forecast for Others Market (Billion US$), 2022 - 2027
Figure 27: North America - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2021
Figure 28: North America - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2022 - 2027
Figure 29: Europe - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2021
Figure 30: Europe - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2022 - 2027
Figure 31: Asia-Pacific - Cardiac Bio Implant Devices Market (Billion US$), 2018 - 2021
Figure 32: Asia-Pacific - Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2022 - 2027
Figure 33: Latin America - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2021
Figure 34: Latin America - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2022 - 2027
Figure 35: Middle East and Africa - Cardiac Bio Implant Devices Market (Million US$), 2018 - 2021
Figure 36: Middle East and Africa - Forecast for Cardiac Bio Implant Devices Market (Million US$), 2022 - 2027
Figure 37: Agilent Technologies - Global Revenue (Billion US$), 2018 - 2021
Figure 38: Agilent Technologies - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 39: Eurofins Scientific - Global Revenue (Billion US$), 2018 - 2021
Figure 40: Eurofins Scientific - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 41: F. Hoffman-La Roche - Global Revenue (Billion US$), 2018 - 2021
Figure 42: F. Hoffman-La Roche - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 43: Illumina, Inc. - Global Revenue (Billion US$), 2018 - 2021
Figure 44: Illumina, Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 45: Natera, Inc. - Global Revenue (Million US$), 2018 - 2021
Figure 46: Natera, Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 47: PerkinElmer Inc. - Global Revenue (Billion US$), 2018 - 2021
Figure 48: PerkinElmer Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 49: Quest Diagnostics - Global Revenue (Billion US$), 2018 - 2021
Figure 50: Quest Diagnostics - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 51: Thermo Fisher Scientific - Global Revenue (Billion US$), 2018 - 2021
Figure 52: Thermo Fisher Scientific - Forecast for Global Revenue (Billion US$), 2022 - 2027
List Of Tables:
Table 01: Global - Cardiac Bio Implant Devices Market Share by Type (Percent), 2018 - 2021
Table 02: Global - Forecast for Cardiac Bio Implant Devices Market Share by Type (Percent), 2022 - 2027
Table 03: Global - Cardiac Bio Implant Devices Market Share by Application (Percent), 2018 - 2021
Table 04: Global - Forecast for Cardiac Bio Implant Devices Market Share by Application (Percent), 2022 - 2027
Table 05: Global - Cardiac Bio Implant Devices Market Share by End-User (Percent), 2018 - 2021
Table 06: Global - Forecast for Cardiac Bio Implant Devices Market Share by End-User (Percent), 2022 - 2027
Table 07: Global - Cardiac Bio Implant Devices Market Share by Region (Percent), 2018 - 2021
Table 08: Global - Forecast for Cardiac Bio Implant Devices Market Share by Region (Percent), 2022 - 2027
Note: Product cover images may vary from those shown
  • Agilent Technologies
  • Eurofins Scientific
  • F. Hoffman-La Roche
  • Illumina, Inc.
  • Natera, Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...